Screening, Prevention, Etiology, and Cancer Survivorship
- Institution
- UNIVERSITY OF MINNESOTA, MN
- Principal investigator
- Anne H. Blaes
- Funding
- $45K
- Duration
- 1998–2029
Moonbase score
Still being scored
Abstract
Screening, Prevention, Etiology, and Cancer Survivorship Program Summary The Screening, Prevention, Etiology, and Cancer Survivorship (SPECS) Program advances research across the broad spectrum of cancer control, including etiology, prevention, early detection, treatment, and survivorship. SPECS research coalesces around 4 research themes: 1) Reducing the harms of tobacco, 2) Preventing cancer through screening and intervention, 3) Improving cancer outcomes, and 4) Childhood cancer epidemiology. SPECS members are focused on unique cancer concerns in our catchment area, including cancer disparities in special populations and elevated rates of melanoma and hematologic cancers. The impact of the Program is evident with research findings leading to changes in policy around commercial tobacco products and national guidelines for cancer screening. Three Specific Aims support the research themes of the SPECS Program: 1) Prevent cancer through identification of risk and protection factors and develop novel approaches to reduce these risks, 2) Improve cancer outcomes with tailored screening and novel interventions in high-risk populations, and 3) Identify factors that impact prognosis and quality of life among cancer survivors. The SPECS Program includes 50 members, representing 6 schools and 20 departments, and has 2 Co-Leaders: Anne Blaes, MD, MS, a Professor and Division Director of Hematology, Oncology, and Transplantation in the Medical School; and Heather Nelson, MPH, PhD, a Professor in the Division of Epidemiology and Community Health in the School of Public Health. For the last budget year, these members were supported by $10.5 million in cancer-relevant research funding (direct costs), of which $4.8 million is from the National Cancer Institute. The Masonic Cancer Center (MCC) has supported the work of the Program in several value-added ways. The Analytical Biochemistry Shared Resource facilitates biomarker work, and the Biostatistics and Cancer Informatics Shared Resources support the design of studies and analysis of data. Community Outreach and Engagement has provided data on cancer research needs within our catchment area and provided guidance to members on conducting community-engaged research. In addition, MCC has provided strategic investment through pilot project funding. The Program, in turn, brings added value to MCC by bringing clinical and population-based perspectives with a focus of translating research to practice and policy and addressing health equity and cancer concerns in our catchment area. Mentoring and training are a priority for the Program, with a strong track record of early-career investigators developing independent research programs. Future directions for the SPECS Program include 2 new initiatives, one around aging and cancer and a second on environmental exposures and cancer.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MINNESOTA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of MinnesotaNot yet scored
Understanding the impact of survivorship care plans on health outcomes in cancer survivors
Anne H. Blaes · $350K · 2024–2026
- NIH · University of Minnesota73
Development and Translation of an Intracranial Auditory Nerve Implant
Meredith Evelyn Adams · $1.5M · 2018–2027
- NIH · University of Minnesota66
Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy
Colum D Mackinnon · $787K · 2022–2027